# Efficacy and Safety of Once-Daily Ciprodexa Otic Foam Compared to Twice-daily Ciprodex Ear Drops in Acute Otitis Externa

> **NCT01359098** · PHASE2 · COMPLETED · sponsor: **Otic Pharma** · enrollment: 100 (estimated)

## Conditions studied

- Otitis Externa
- Otorhinolaryngologic Diseases
- Ear Diseases
- Otitis

## Interventions

- **DRUG:** Ciprodex Otic Suspension
- **DRUG:** Ciprodexa Otic Foam

## Key facts

- **NCT ID:** NCT01359098
- **Lead sponsor:** Otic Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2011-10
- **Final completion:** 2011-11
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2011-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01359098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01359098, "Efficacy and Safety of Once-Daily Ciprodexa Otic Foam Compared to Twice-daily Ciprodex Ear Drops in Acute Otitis Externa". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01359098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*